Innate Immune Response to Aspergillus fumigatus Cell Wall Carbohydrates
对烟曲霉细胞壁碳水化合物的先天免疫反应
基本信息
- 批准号:10212945
- 负责人:
- 金额:$ 19.98万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-08-21 至 2024-07-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAntifungal AgentsAntifungal TherapyAntigen PresentationAntigensAspergillosisAspergillus fumigatusAwardBiological AssayCandidaCarbohydrate BiochemistryCarbohydratesCell WallClinicalCommunicable DiseasesComplexCritical PathwaysCryptococcusDataDefectDiseaseFellowshipFunctional disorderFungal AntigensGeneral HospitalsGenerationsGlucansGoalsGrantGrowthHealthHematopoieticImmuneImmune responseImmune signalingImmune systemImmunityImmunocompromised HostImmunologyImmunosuppressionIncidenceIndividualInfectionInflammatoryInflammatory ResponseInnate Immune ResponseInnate Immune SystemK-Series Research Career ProgramsMacrophage-1 AntigenMassachusettsMeasurementMediatingMentorsMentorshipMolecularMolecular BiologyMorbidity - disease rateMycosesOrgan TransplantationPathway interactionsPatient-Focused OutcomesPatientsPatternPattern recognition receptorPhagocytosisPhagosomesPharmacologyPhysiciansPlayPolystyrenesPopulationPrevalenceProcessProductionProtein-Carbohydrate InteractionProteinsProteomicsReactive Oxygen SpeciesResearchResearch PersonnelRoleScientistSentinelSignal PathwaySignal TransductionSkin TissueSolidTechnologyTrainingTraining ProgramsTransplant RecipientsVirulenceWomancarbohydrate binding proteincareercareer developmentcell typechemical conjugatecytokinedectin 1experiencefungusgalactomannangalactosaminogalactanhuman pathogenimmunomodulatory therapiesimproved outcomemacrophagemortalitymouse dectin-2mutantneutrophilnovelnovel therapeutic interventionparticlepathogenpathogenic fungusprogramsreceptorrecruitresponsesoft tissue
项目摘要
Project Summary/Abstract
Invasive fungal infections are associated with exceptionally high mortality rates often exceeding 80%, and are
increasing in incidence due to a rapidly growing population of immunocompromised patients. Aspergillus
fumigatus is one of the leading causes of invasive fungal infections and causes a spectrum of diseases ranging
from skin and soft tissue to disseminated infections. Amongst patients that received hematopoietic or solid-
organ transplants, approximately 10% will develop invasive aspergillosis. The persistently high mortality rates
despite antifungal therapy highlights the deficiencies in our current antifungal armamentarium and the critical
role that the immune system plays in the clearance of infections. Effective fungal immunity is initiated by innate
immune recognition of the complex, carbohydrate fungal cell wall followed by cytokine production, ROS
generation, phagocytosis and killing of pathogens. The profile of fungal carbohydrate antigens displayed on the
fungal cell wall dictates the pattern recognition receptors engaged and influences whether a protective or non-
protective response is generated. In this application, the candidate proposes a K08 Mentored Clinical Scientist
Research Career Development Award grant that will characterize molecular mechanisms of macrophages and
neutrophil response to the A. fumigatus carbohydrates, galactomannan (GALM) and galactosaminogalactan
(GAG). To define the subcellular pathways involved in the response to these carbohydrates, novel fungal like
particles (FLP) composed of single purified carbohydrates stably coating polystyrene beads will be utilized.
Preliminary data suggests that Dectin-2 is a receptor for GALM. Specific Aim 1 will define the role of Dectin-2
in macrophages and neutrophil recognition and response to both soluble and cell wall associated GALM,
specifically probing the role of Dectin-2 and the downstream effector Syk in cytokine production, phagocytosis,
and phagosomal maturation. Specific Aim 2 seeks to define the molecular pathways that mediate macrophage
and neutrophil responses to soluble and cell wall-associated GAG. This aim will define signaling pathways and
receptors critical for GAG mediated immunosuppression and define the role of GAG in cytokine production,
ROS generation, and phagocytosis. The candidate is a physician-scientist and has completed a clinical
fellowship in the combined Massachusetts General Hospital and Brigham and Women's Infectious Diseases
Program. She has research experience in fungal molecular biology having devoted her graduate training to
defining signaling pathways involved in virulence and the generation of diversity in the human pathogens,
Candida and Cryptococcus. Her overall career goal is to be an independent investigator capable of probing the
host-pathogen interface. Therefore this career development grant outlines a didactic, mentoring, and scientific
research plan that will provide the necessary training in host immunology necessary to study the dynamic
interplay between host and pathogen and become a productive independent physician-scientist.
项目摘要/摘要
侵袭性真菌感染与极高的死亡率有关,通常超过80%,而且
由于免疫功能低下患者的人口迅速增长,发病率不断上升。曲霉菌
烟曲霉菌是侵袭性真菌感染的主要原因之一,可引起一系列疾病
从皮肤和软组织到播散性感染。在接受造血或固体治疗的患者中-
器官移植,大约10%会发展成侵袭性曲霉病。居高不下的死亡率
尽管抗真菌治疗突出了我们目前抗真菌治疗的不足和关键
免疫系统在清除感染方面所起的作用。有效的真菌免疫是由先天启动的
免疫识别复杂的碳水化合物真菌细胞壁,随后产生细胞因子,ROS
病原体的产生、吞噬和杀灭。上显示的真菌碳水化合物抗原的概况
真菌细胞壁决定了模式识别受体的参与,并影响保护性或非保护性
产生保护性反应。在本申请中,候选人推荐一名K08临床科学家导师
研究事业发展奖授予将表征巨噬细胞和
中性粒细胞对烟曲霉碳水化合物、半乳甘露聚糖(GALM)和半乳糖氨基半乳糖的反应
(插嘴)。为了确定参与对这些碳水化合物的反应的亚细胞途径,新型真菌如
将使用由稳定包覆聚苯乙烯珠粒的单一纯化碳水化合物组成的颗粒(FLP)。
初步数据表明Dectin-2是GALM的受体。具体目标1将定义Dectin-2的作用
在巨噬细胞和中性粒细胞对可溶性和细胞壁相关的Galm的识别和反应中,
特别是探讨Dectin-2及其下游效应蛋白Syk在细胞因子产生、吞噬、
吞噬小体成熟。特异性目标2试图定义介导巨噬细胞的分子途径
中性粒细胞对可溶性和细胞壁相关的GAG的反应。这一目标将定义信号通路和
GAG介导的免疫抑制的关键受体,并确定GAG在细胞因子产生中的作用,
ROS生成和吞噬作用。应聘者是一名内科科学家,并已完成临床
马萨诸塞州总医院与布里格姆和妇女传染病联合医院的奖学金
程序。她在真菌分子生物学方面有研究经验,她的研究生培训致力于
定义涉及毒力和人类病原体多样性产生的信号通路,
念珠菌和隐球菌属。她的整个职业目标是成为一名能够调查
宿主-病原体界面。因此,这份职业发展基金概述了一种说教、指导和科学的
研究计划将提供研究动态所需的宿主免疫学方面的必要培训
宿主和病原体之间的相互作用,并成为一名富有成效的独立内科科学家。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jennifer Lynne Reedy其他文献
Jennifer Lynne Reedy的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jennifer Lynne Reedy', 18)}}的其他基金
Innate Immune Response to Aspergillus fumigatus Cell Wall Carbohydrates
对烟曲霉细胞壁碳水化合物的先天免疫反应
- 批准号:
10450028 - 财政年份:2019
- 资助金额:
$ 19.98万 - 项目类别:
相似海外基金
Extending the utility and durability of antifungal agents via innovative treatment regimens that minimise drug resistance
通过创新治疗方案最大限度地减少耐药性,延长抗真菌药物的效用和持久性
- 批准号:
MR/Y002164/1 - 财政年份:2024
- 资助金额:
$ 19.98万 - 项目类别:
Research Grant
Engineering microbial cell factories for production of improved polyene antifungal agents
工程微生物细胞工厂用于生产改进的多烯抗真菌剂
- 批准号:
2898887 - 财政年份:2023
- 资助金额:
$ 19.98万 - 项目类别:
Studentship
Morphological profiling for the development of antifungal agents
用于开发抗真菌药物的形态分析
- 批准号:
22H02216 - 财政年份:2022
- 资助金额:
$ 19.98万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
An efficient approach to find therapeutically effective antifungal agents
寻找治疗有效的抗真菌药物的有效方法
- 批准号:
22K05337 - 财政年份:2022
- 资助金额:
$ 19.98万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Investigating light-activated therapeutic compounds as antifungal agents.
研究光激活治疗化合物作为抗真菌剂。
- 批准号:
2753345 - 财政年份:2022
- 资助金额:
$ 19.98万 - 项目类别:
Studentship
Discovery of novel therapeutic agents for biliary tract and pancreatic cancer based on antifungal agents
基于抗真菌药物的胆道癌和胰腺癌新型治疗药物的发现
- 批准号:
20H03533 - 财政年份:2020
- 资助金额:
$ 19.98万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of antifungal agents that target essential protein kinases in A. fumigatus.
开发针对烟曲霉必需蛋白激酶的抗真菌剂。
- 批准号:
2456629 - 财政年份:2020
- 资助金额:
$ 19.98万 - 项目类别:
Studentship
Elucidation of tip growth factor of fungi and construction of screeing system for antifungal agents
真菌尖端生长因子的阐明及抗真菌药物筛选体系的构建
- 批准号:
19K05738 - 财政年份:2019
- 资助金额:
$ 19.98万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Ambruticins: An inspiration to develop novel biocatalysts and antifungal agents
Ambruticins:开发新型生物催化剂和抗真菌剂的灵感
- 批准号:
2107517 - 财政年份:2018
- 资助金额:
$ 19.98万 - 项目类别:
Studentship














{{item.name}}会员




